FLEX vs VRTX · P/E 23, rev $6.40B vs P/E 30, rev $12.00B
Flex Ltd (FLEX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Flex Ltd (FLEX) is a electronic components company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
FLEX currently screens at market cap $18.12B and trailing P/E 23.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the FLEX and VRTX stock pages for the full models.
Not investment advice.